The objective of the proposed project is to achieve a detailed and precise understanding of the molecular mechanism of genetic regulation, at a level at which specific changes in the operation of this mechanism could be predicted and engineered. The ability to predict and control modifications to the function of genetic regulatory mechanisms will have far reaching consequences to the ability to treat genetic diseases and to use the mechanisms as targets for rational drug design, but existing knowledge is as yet insufficient to reach these goals. The trp-repressor from E. coli was chosen as a model system for detailed study, because it is one of the smallest and simplest complete regulatory systems available today. Starting with the known structures of the repressor protein, with and without the activator L-tryptophan, and of the ternary DNA-repressor-L-trp complex, it is possible to systematically investigate the role of each structural element (amino acid residue) in (1) maintaining specific contacts with the L-trp ligand and (2) with the operator DNA and (3) transmitting the signal regulating DNA binding between the binding sites. This will be achieved by studying point and multiple mutations which are known to alter the conformation and dynamics of the system. Very promising initial results have already been obtained with some of the mutants, providing clear directions for future studies. Correlation of the findings should allow an understanding of the signaling code and the design of the regulatory apparatus.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM033385-13A1
Application #
2749821
Study Section
Biophysical Chemistry Study Section (BBCB)
Project Start
1985-07-01
Project End
2003-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
13
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Stanford University
Department
Miscellaneous
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Finucane, Michael D; Jardetzky, Oleg (2003) Surface plasmon resonance studies of wild-type and AV77 tryptophan repressor resolve ambiguities in super-repressor activity. Protein Sci 12:1613-20
Wang, Yunjun; Jardetzky, Oleg (2002) Probability-based protein secondary structure identification using combined NMR chemical-shift data. Protein Sci 11:852-61
Wang, Yunjun; Jardetzky, Oleg (2002) Investigation of the neighboring residue effects on protein chemical shifts. J Am Chem Soc 124:14075-84
Gryk, M R; Jardetzky, O (1996) AV77 hinge mutation stabilizes the helix-turn-helix domain of trp repressor. J Mol Biol 255:204-14
Gryk, M R; Jardetzky, O; Klig, L S et al. (1996) Flexibility of DNA binding domain of trp repressor required for recognition of different operator sequences. Protein Sci 5:1195-7
Taylor, K L; Strobel, F; Yue, K T et al. (1995) Isolation and identification of a protoheme IX derivative released during autolytic cleavage of human myeloperoxidase. Arch Biochem Biophys 316:635-42
Zheng, Z; Czaplicki, J; Jardetzky, O (1995) Backbone dynamics of trp repressor studied by 15N NMR relaxation. Biochemistry 34:5212-23
Finucane, M D; Jardetzky, O (1995) Mechanism of hydrogen-deuterium exchange in trp repressor studied by 1H-15N NMR. J Mol Biol 253:576-89
Zheng, Z; Gryk, M R; Finucane, M D et al. (1995) Investigation of protein amide-proton exchange by 1H longitudinal spin relaxation. J Magn Reson B 108:220-34
Schmitt, T H; Zheng, Z; Jardetzky, O (1995) Dynamics of tryptophan binding to Escherichia coli Trp repressor wild type and AV77 mutant: an NMR study. Biochemistry 34:13183-9

Showing the most recent 10 out of 26 publications